Why Three Appetite Hormones Beat One: And What It Means If You've Heard of GLP-1s

Amarasate® triggers three satiety hormones—GLP-1, CCK, and PYY—at once, unlike GLP-1 drugs. A clinical trial shows it supports fat loss while preserving muscle.

Why Three Appetite Hormones Beat One: And What It Means If You've Heard of GLP-1s

Key Takeaways

  • Amarasate isn't a drug — it's a hop flower extract (yes, the same plant used in beer but a very specific type) taken as a capsule before meals, under the brand Calocurb.
  • It triggers the release of three natural appetite hormones: GLP-1 (the same hormone that drugs like Ozempic mimic), CCK, and PYY.1
  • In a 24-week clinical trial of 150 people, Amarasate users lost an average of 4.8% of their body weight — and when you account for the muscle they didn’t lose, the real fat loss works out to 5.3%.2
  • Unlike GLP-1 medications, which typically cause people to lose muscle along with fat, Amarasate users actually preserved muscle (and in fact showed a small increase of 2 lb/0.9 kg on average over 24 weeks).
  • Researchers believe this muscle-sparing effect comes specifically from PYY, one of the two extra hormones that GLP-1 drugs don't meaningfully touch.
  • Amarasate is being explored as an alternative to GLP-1 drugs, a way to ease off them, or something to take alongside them to help protect muscle.

GLP-1 drugs that mimic a hormone called glucagon-like peptide-1 are well-known; they include Wegovy®/Ozempic® and Zepbound®/Mounjaro® and have become famous for helping people lose weight. But there's a lesser-known, non-prescription and natural option that works a bit differently — and a new clinical trial suggests it might have a real advantage: it helps people lose weight without losing muscle along the way.

That option is Amarasate®, a hop extract that's the active ingredient in a supplement called Calocurb®. Here's the interesting part: instead of targeting just one appetite hormone (like GLP-1 drugs do), Amarasate triggers your gut to release three different "feel full" hormones at once.3 And that combination appears to be the reason it preserves muscle mass — something GLP-1 medications are known to struggle with.

This article breaks down what those three hormones actually do, what the latest trial found, and why it matters.

A Quick Word on How Appetite Hormones Work

Your gut isn't just a digestion tube — it's actually one of the largest hormone-producing systems in your body. Specialized cells lining your intestines, called enteroendocrine cells, make up only about 1% of your gut lining but form the largest endocrine (hormone-producing) system in the human body.4 These cells carry various receptors for different substances (bitter or sweet ones, proteins, fats, etc) to sense what you're eating and, in response, release hormones into your bloodstream and along dedicated nerve pathways that connect straight to the vagus nerve — your body's main gut-to-brain highway.5 The message these hormones send to your brain is often simply: "you've had enough" or "slow down."

This is exactly the system that GLP-1 drugs exploit — they mimic one of these natural hormones (GLP-1) to turn down appetite. Amarasate works differently: rather than being a synthetic copy of a hormone, it's a very bitter plant compound that stimulates your own gut cells to release hormones — and it turns out it nudges the release of three, not just one.6 These gut cells vary somewhat from person to person and region to region,7 and because scientists are still refining exactly how to classify them,89 researchers are still learning the full picture — but the effects of Amarasate on these three hormones specifically have now been measured directly.

Meet the Three Hormones

GLP-1 — the one you've probably heard of

GLP-1 is the hormone that semaglutide (Ozempic/Wegovy), and similar drugs are designed to imitate. Natural GLP-1 is released after eating and tells your brain you're satisfied, while also slowing down how fast your stomach empties, so fullness lasts longer.

In the research, a single 500 mg dose of Amarasate increased people's natural GLP-1 levels to 640% of their normal baseline — comfortably above the roughly 4-fold increase scientists believe is needed to actually reduce how much someone eats.1011 That's a big part of why it works. It's also worth noting that Amarasate itself is barely absorbed into the bloodstream (less than 1.5%), which means it keeps working all the way down the length of the gut, including areas food alone wouldn't typically reach with this kind of signal.12

CCK — the one that helps you digest, feel full, and burn energy too

CCK (cholecystokinin) probably isn't a hormone you've heard of, but it's a heavy lifter. It's released mainly in response to fat and protein in a meal, and it does double duty:

  • In your gut: it tells your gallbladder to release bile (which helps digest fat), slows stomach emptying, and helps you absorb protein.13
  • In your brain: it sends direct signals of fullness, and it works together with another hormone, leptin, to reinforce that "I'm satisfied" feeling and burn energy (thanks, leptin!).14

CCK may also help burn fat in a few other indirect ways, based on lab and animal studies. It raises levels of a hormone called adiponectin,15 which helps the body burn fat for energy, supports healthy fat storage, and keeps fat from building up in places it shouldn't (like the liver).161718 CCK also boosts a hormone called leptin, which does more than just tell your brain you're full — it also acts directly on fat tissue to break down stored fat, encourage the body to burn it for fuel, and reduce the creation of new fat.19 On top of that, lab studies suggest CCK can help turn regular white fat into a more active, calorie-burning type of fat, sometimes called "beige fat."2021

It's worth noting that none of these individual effects have been proven, on their own, to cause meaningful weight loss in human studies. But together, they may help explain some of the fat-burning results seen in the Amarasate study, where CCK levels were increased.

Amarasate increased CCK levels 600% in the same study — again, well above the roughly 3.6-fold threshold thought necessary to reduce food intake.2223 There's also a knock-on benefit: the bile that CCK triggers can itself stimulate more GLP-1 release further down the gut, so the hormones reinforce each other.24

PYY — the one that may protect your muscle

PYY (peptide tyrosine tyrosine) is the least talked-about of the three, but it may be the most important piece of this particular puzzle. PYY is normally released after eating, especially after high-protein or high-fat meals (though this response is somewhat blunted in people who are obese).25 Like GLP-1 and CCK it has effects within your brain to help put the brakes on your appetite and also slows down digestion — sometimes called the "colonic brake," because it also smooths out blood sugar spikes after meals.2627

But here's the part that's caught researchers' attention: PYY receptors have also been found on skeletal muscle itself and on the stem cells responsible for repairing and building new muscle fibers.28 In other words, PYY doesn't just talk to your brain — it may also talk directly to your muscles, helping them repair and adapt rather than break down.29 Levels of PYY inside muscle tissue rise during low-energy states (like when you're eating less to lose weight), which hints that your body may lean on PYY to help protect muscle when it's under that kind of stress.30

Amarasate raised PYY by 1.7 times in the initial study — a smaller bump than GLP-1 or CCK, and short of the roughly 3-fold threshold thought to directly reduce food intake on its own.3132 But researchers believe it may still be meaningful, especially in combination with the other two hormones, and especially for muscle preservation over time.

By increasing levels of these three "stop eating" hormones, Calocurb acts as an all-natural "bitter brake", helping people feel full faster and for longer, and reducing how much they eat.

GLP-1
  • Activates brain appetite control centres
  • Slows down stomach emptying
Calocurb increases GLP-1 by 640% Feel full faster and longer
Weight loss: >9× more than willpower alone
CCK
  • Activates brain appetite control centres
  • Slows down stomach emptying
  • Stimulates leptin release from fat cells
  • Aids in fat digestion
Calocurb increases CCK by 600% Enhanced energy burning
Fat loss: >6× Visceral fat loss: >3.5× more than placebo
PYY
  • Activates brain appetite control centres
  • Slows down stomach emptying
  • Involved in repair and growth of muscle fibres
Calocurb increases PYY by 170% Helps build and repair muscles
Muscle mass preserved during weight loss

What the Latest Study Actually Found

The headline result comes from a 24-week, placebo-controlled trial of 150 people.33 Participants took two 125 mg Calocurb capsules about an hour before their two largest meals each day. Here's what happened, compared with the placebo group:

What was measured Calocurb (Amarasate) Placebo
Average weight loss 4.8% 0.5%
Weight loss adjusted for muscle change 5.3% 0.7%
Change in muscle mass Gained 2.0 lb / 0.9 kg Gained 0.4 lb / 0.2 kg

Table 1: 24-week trial outcomes — Calocurb (Amarasate) vs placebo. Walker E et al., Obes Pillars, 2026.

Both differences in weight loss were statistically significant, meaning they're unlikely to be due to chance.34 Side effects were minimal — in fact, only one person in each group (treatment and placebo) dropped out because of side effects, which is a notably low number for a weight-loss study.35

To put the muscle result in context: with most weight-loss approaches — and especially with GLP-1 medications — somewhere between a quarter and a third of the weight lost is actually muscle, not fat. That's a real concern, because losing muscle can slow your metabolism, weaken you physically, and make it harder to keep weight off long-term. Amarasate users, by contrast, at the very least, maintained their muscle, on top of losing fat.36

So Why Does It Protect Muscle When GLP-1 Drugs Don't?

This is really the heart of the story. Researchers believe the answer lies in the PYY, one of the two extra hormones GLP-1 drugs don't touch.

There's also a related clue: people with sarcopenia (age- or illness-related muscle loss) tend to have higher GLP-1 levels, and lab studies suggest GLP-1 plays a role in normal muscle repair.37 That may partly explain why long-term GLP-1 drug use is associated with muscle loss — it's a synthetic, one-note version of a hormone system that naturally works as a trio. Amarasate, by stimulating all three hormones together the way your body would naturally, seems to sidestep that downside.

How Might This Be Used?

Because Amarasate works through a different (and broader) mechanism than GLP-1 drugs, it's being explored in a few different roles:

As an alternative to GLP-1 medication, for people who prefer a non-prescription option or can't tolerate the drugs.

As an "off-ramp" for people coming off GLP-1 medications, to help maintain results.

As a complementary add-on taken alongside GLP-1 drugs, specifically to help counter the muscle loss and the drop in the body's own GLP-1 production that can come with long-term use.38

Natural appetite support

Three hormones. One capsule.

Calocurb contains Amarasate, the only clinically studied ingredient shown to stimulate GLP-1, CCK, and PYY simultaneously — supporting appetite control and muscle preservation naturally.

Shop now See the science
Calocurb bottle

Frequently Asked Questions

Is Amarasate the same as a GLP-1 drug like Ozempic?
No. Semaglutide (Ozempic/Wegovy) is a GLP-1 prescription medication that mimics one specific hormone, tirzepatide (Zepbound/Mounjaro) also mimics a second hormone called GIP, and retatrutide mimics these two plus a third one (glucagon) — but none of these act on CCK or PYY. Amarasate is a plant-derived supplement (from hops) that stimulates your body to release three of its own natural hormones — GLP-1 among them, but also CCK and PYY.
Do I need a prescription for Calocurb?
No, Calocurb (which contains Amarasate) is sold as an over-the-counter supplement, not a prescription medication.
How is it taken?
In the clinical trial, participants took two 125 mg capsules about an hour before their two largest meals of the day to help you feel full faster so you eat less, and also feel full longer. You can also take it to avoid eating altogether, for example, an hour before you usually start to get the late-night "munchies" or to get you through fasting periods if you do time-restricted eating. It should always be taken on an empty stomach with a large glass of water.
How much weight can I expect to lose?
In the 24-week trial, the average was 4.8% of body weight (5.3% once muscle gain was factored in), compared with 0.5% in the placebo group. Individual results vary; while this is meaningfully less than what was demonstrated in the pivotal trials with GLP-1 medications like semaglutide or tirzepatide, real-life use of these drugs show typical weight loss of 11% and 14%, respectively.
Why does muscle preservation matter so much?
Muscle isn't just about strength — it also plays a big role in your metabolism. Losing muscle during weight loss can make it harder to keep weight off and can leave you feeling weaker. Many weight-loss methods, including GLP-1 drugs, cause meaningful muscle loss (often 25–35% of total weight lost). Preserving muscle while losing fat is a much better outcome.
Can I take Calocurb together with a GLP-1 medication?
It's being explored as a complementary option for exactly that reason — to help offset the muscle loss associated with GLP-1 drugs and maintain your natural GLP-1 production (which is blunted by the medications). As always, check with your doctor before combining any supplement with a prescription medication.
Are there side effects?
In the clinical trial, side effects were minimal, with dropout rates due to side effects no higher than in the placebo group. A small minority of users experience transient diarrhea when they start Calocurb, as their bodies get used to it; that's why you should introduce it gradually over 5 days, as indicated on the packaging. As with any supplement, individual reactions can vary, so it's worth discussing with a healthcare provider, especially if you have existing health conditions.
Where does the name "Amarasate" come from?
It's derived from two Latin words: satietas, meaning fullness, and amara, meaning bitter. It's a purified extract of hop flowers (the same plant used to flavor beer) — specifically, the bitter compounds in hops, which is why it works: it activates bitter-taste receptors all the way down the lining of your intestines that trigger these hormone releases.
Dr. Tracey Lambert, MBChB, Calocurb

Written by

Dr. Tracey Lambert, MBChB, Calocurb

← Back to blog

References

  1. Walker EG, Lo KR, Pahl MC, et al. An extract of hops (Humulus lupulus L.) modulates gut peptide hormone secretion and reduces energy intake in healthy-weight men: a randomized, crossover clinical trial. Am J Clin Nutr. 2022;115(3):925-940. doi:10.1093/ajcn/nqab418
  2. Walker E, Lo K, Smirk I, et al. Bitter hop nutraceutical stimulates fat mass loss while preserving muscle mass in a cohort of individuals with overweight or obesity receiving diet and exercise advice. Obes Pillars. 2026;19:100299. Published July 17, 2026. doi:10.1016/j.obpill.2026.100299
  3. Walker EG, Lo KR, Pahl MC, et al. An extract of hops (Humulus lupulus L.) modulates gut peptide hormone secretion and reduces energy intake in healthy-weight men: a randomized, crossover clinical trial. Am J Clin Nutr. 2022;115(3):925-940. doi:10.1093/ajcn/nqab418
  4. Atang R, Singh V, In JG. Intestinal enteroendocrine cells: present and future druggable targets. Int J Mol Sci. 2023;24(10):8836. doi:10.3390/ijms24108836
  5. Atang R, Singh V, In JG. Intestinal enteroendocrine cells: present and future druggable targets. Int J Mol Sci. 2023;24(10):8836. doi:10.3390/ijms24108836
  6. Walker EG, Lo KR, Pahl MC, et al. An extract of hops (Humulus lupulus L.) modulates gut peptide hormone secretion and reduces energy intake in healthy-weight men: a randomized, crossover clinical trial. Am J Clin Nutr. 2022;115(3):925-940. doi:10.1093/ajcn/nqab418
  7. Walker E, Walmsley R, Richards K, McGill A-T, Poppitt S, Ingram J. Gastrointestinal bitter taste receptors exhibit inter-regional and inter-individual variation. Preprints 2024, 2024101917. doi:10.20944/preprints202410.1917.v1
  8. Kuhre RE, Deacon CF, Holst JJ, Petersen N. What is an L-cell and how do we study the secretory mechanisms of the L-cell? Front Endocrinol (Lausanne). 2021;12:694284. doi:10.3389/fendo.2021.694284
  9. Fothergill LJ, Furness JB. Diversity of enteroendocrine cells investigated at cellular and subcellular levels: the need for a new classification scheme. Histochem Cell Biol. 2018;150(6):693-702. doi:10.1007/s00418-018-1746-x
  10. Walker EG, Lo KR, Pahl MC, et al. An extract of hops (Humulus lupulus L.) modulates gut peptide hormone secretion and reduces energy intake in healthy-weight men: a randomized, crossover clinical trial. Am J Clin Nutr. 2022;115(3):925-940. doi:10.1093/ajcn/nqab418
  11. Lim JJ, Poppitt SD. How satiating are the 'satiety' peptides: a problem of pharmacology versus physiology in the development of novel foods for regulation of food intake. Nutrients. 2019;11(7):1517. doi:10.3390/nu11071517
  12. New Zealand Institute for Plant and Food Research. Data on file.
  13. Okonkwo O, Zezoff D, Adeyinka A. Biochemistry, Cholecystokinin. In: StatPearls. Treasure Island (FL): StatPearls Publishing; May 1, 2023. Accessed June 5, 2026. https://www.ncbi.nlm.nih.gov/books/NBK534204/
  14. Okonkwo O, Zezoff D, Adeyinka A. Biochemistry, Cholecystokinin. In: StatPearls. Treasure Island (FL): StatPearls Publishing; May 1, 2023. Accessed June 5, 2026. https://www.ncbi.nlm.nih.gov/books/NBK534204/
  15. Plaza A, Merino B, Del Olmo N, Ruiz-Gayo M. The cholecystokinin receptor agonist, CCK-8, induces adiponectin production in rat white adipose tissue. Br J Pharmacol. 2019;176(15):2678-2690. doi:10.1111/bph.14690
  16. Yamauchi T, Kamon J, Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 2002;8(11):1288-1295. doi:10.1038/nm788
  17. Yoon MJ, Lee GY, Chung JJ, Ahn YH, Hong SH, Kim JB. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha. Diabetes. 2006;55(9):2562-2570. doi:10.2337/db05-1322
  18. Stern JH, Rutkowski JM, Scherer PE. Adiponectin, leptin, and fatty acids in the maintenance of metabolic homeostasis through adipose tissue crosstalk. Cell Metab. 2016;23(5):770-784. doi:10.1016/j.cmet.2016.04.011
  19. Stern JH, Rutkowski JM, Scherer PE. Adiponectin, leptin, and fatty acids in the maintenance of metabolic homeostasis through adipose tissue crosstalk. Cell Metab. 2016;23(5):770-784. doi:10.1016/j.cmet.2016.04.011
  20. Park HJ, Kim JS, Kim ER, Gu MB, Lee SJ. Nonanoic acid and cholecystokinin induce beige adipogenesis. Food Sci Biotechnol. 2024;34(3):709-720. Published 2024 Sep 10. doi:10.1007/s10068-024-01699-6
  21. Boychenko S, Egorova VS, Brovin A, Egorov AD. White-to-beige and back: adipocyte conversion and transcriptional reprogramming. Pharmaceuticals (Basel). 2024;17(6):790. Published 2024 Jun 16. doi:10.3390/ph17060790
  22. Walker EG, Lo KR, Pahl MC, et al. An extract of hops (Humulus lupulus L.) modulates gut peptide hormone secretion and reduces energy intake in healthy-weight men: a randomized, crossover clinical trial. Am J Clin Nutr. 2022;115(3):925-940. doi:10.1093/ajcn/nqab418
  23. Lim JJ, Poppitt SD. How satiating are the 'satiety' peptides: a problem of pharmacology versus physiology in the development of novel foods for regulation of food intake. Nutrients. 2019;11(7):1517. doi:10.3390/nu11071517
  24. Kuhre RE, Deacon CF, Holst JJ, Petersen N. What is an L-cell and how do we study the secretory mechanisms of the L-cell? Front Endocrinol (Lausanne). 2021;12:694284. doi:10.3389/fendo.2021.694284
  25. Batterham RL, Heffron H, Kapoor S, et al. Critical role for peptide YY in protein-mediated satiation and body-weight regulation. Cell Metab. 2006;4(3):223-233. doi:10.1016/j.cmet.2006.08.001
  26. De Silva A, Bloom SR. Gut hormones and appetite control: a focus on PYY and GLP-1 as therapeutic targets in obesity. Gut Liver. 2012;6(1):10-20. doi:10.5009/gnl.2012.6.1.10
  27. Nguyen NT, Park JH. Peptide YY in type 2 diabetes: a complementary gut hormone with therapeutic potential beyond GLP-1. Nutrients. 2025;17(21):3468. doi:10.3390/nu17213468
  28. Gheller BJ, Blum JE, Merritt EK, Cummings BP, Thalacker-Mercer AE. Peptide YY (PYY) is expressed in human skeletal muscle tissue and expanding human muscle progenitor cells. Front Physiol. 2019;10:188. doi:10.3389/fphys.2019.00188
  29. Fukada SI, Higashimoto T, Kaneshige A. Differences in muscle satellite cell dynamics during muscle hypertrophy and regeneration. Skelet Muscle. 2022;12(1):17. doi:10.1186/s13395-022-00300-0
  30. Walker EG, Lo KR, Pahl MC, et al. An extract of hops (Humulus lupulus L.) modulates gut peptide hormone secretion and reduces energy intake in healthy-weight men: a randomized, crossover clinical trial. Am J Clin Nutr. 2022;115(3):925-940. doi:10.1093/ajcn/nqab418
  31. Lim JJ, Poppitt SD. How satiating are the 'satiety' peptides: a problem of pharmacology versus physiology in the development of novel foods for regulation of food intake. Nutrients. 2019;11(7):1517. doi:10.3390/nu11071517
  32. Walker E, Lo K, Smirk I, et al. Bitter hop nutraceutical stimulates fat mass loss while preserving muscle mass in a cohort of individuals with overweight or obesity receiving diet and exercise advice. Obes Pillars. 2026;19:100299. Published July 17, 2026. doi:10.1016/j.obpill.2026.100299
  33. Walker E, Lo K, Smirk I, et al. Bitter hop nutraceutical stimulates fat mass loss while preserving muscle mass in a cohort of individuals with overweight or obesity receiving diet and exercise advice. Obes Pillars. 2026;19:100299. Published July 17, 2026. doi:10.1016/j.obpill.2026.100299
  34. Walker E, Lo K, Smirk I, et al. Bitter hop nutraceutical stimulates fat mass loss while preserving muscle mass in a cohort of individuals with overweight or obesity receiving diet and exercise advice. Obes Pillars. 2026;19:100299. Published July 17, 2026. doi:10.1016/j.obpill.2026.100299
  35. Huang HH, Wang YJ, Jiang HY, et al. Sarcopenia-related changes in serum GLP-1 level affect myogenic differentiation. J Cachexia Sarcopenia Muscle. 2024;15(5):1708-1721. doi:10.1002/jcsm.13524
  36. Kim SH, Abbasi F, Nachmanoff C, et al. Effect of the glucagon-like peptide-1 analogue liraglutide versus placebo treatment on circulating proglucagon-derived peptides that mediate improvements in body weight, insulin secretion and action: A randomized controlled trial. Diabetes Obes Metab. 2021;23(2):489-498. doi:10.1111/dom.14242
  37. Huang HH, Wang YJ, Jiang HY, et al. Sarcopenia-related changes in serum GLP-1 level affect myogenic differentiation. J Cachexia Sarcopenia Muscle. 2024;15(5):1708-1721. doi:10.1002/jcsm.13524
  38. Kim SH, Abbasi F, Nachmanoff C, et al. Effect of the glucagon-like peptide-1 analogue liraglutide versus placebo treatment on circulating proglucagon-derived peptides that mediate improvements in body weight, insulin secretion and action: A randomized controlled trial. Diabetes Obes Metab. 2021;23(2):489-498. doi:10.1111/dom.14242